首页> 外文期刊>Macedonian Academy of Sciences and Arts: Section of Biological and Medical Sciences >URINE PROTEOMICS IN CLINICAL APPLICATIONS: TECHNOLOGIES, PRIN-CIPAL CONSIDERATIONS AND CLINICAL IMPLEMENTATION
【24h】

URINE PROTEOMICS IN CLINICAL APPLICATIONS: TECHNOLOGIES, PRIN-CIPAL CONSIDERATIONS AND CLINICAL IMPLEMENTATION

机译:临床应用中的尿液蛋白质组学:技术,PRIN-CIPAL注意事项和临床实施

获取原文
           

摘要

The technology platforms for proteome analysis have advanced considerably over the last few years. Due to these improvements the number of studies on the analysis of the proteome/peptidome with the aim of defining biomarkers has escalated. In this review, we will summarise the technical aspects that relate to the proteomics field targeting the discovery of biomarkers for disease diagnosis. We will describe the course from biomarker discovery or ‘potential’ biomarkers to those that are clinically important. We also present several examples of successful proteomic studies that have defined ‘biomarker patterns’ for clinical applications, focussed on urine as a material source and capillary electrophoresis coupled mass spectrometry as a technology. Finally, current challenges and considerations for future studies will be discussed.
机译:在过去的几年中,用于蛋白质组分析的技术平台有了很大的进步。由于这些改进,以定义生物标志物为目的的蛋白质组/肽组分析研究的数量不断增加。在这篇综述中,我们将总结与蛋白质组学领域相关的技术方面,这些领域针对疾病诊断的生物标志物的发现。我们将描述从发现生物标志物或“潜在”生物标志物到具有临床意义的标志物的过程。我们还提供了一些成功的蛋白质组学实例,这些实例已经为临床应用定义了“生物标志物模式”,重点是尿液作为物质来源,毛细管电泳耦合质谱技术。最后,将讨论当前的挑战和对未来研究的考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号